Anti-Parkinsonian drugs. Part II: Drug files, therapy concepts and pharmaceutical care;Parkinson-therapeutika. Teil II: Wirkstoff-dossiers, therapiekonzepte und pharmazeutische betreuung

Deutsche Apotheker Zeitung

Volumn 142, Issue 39, 2002, Pages 62-71

  Hubert, Marcus A ^a   Mayer, Ralf ^a   Müller, Christa E ^a  

^a Pharmazeutisches Institut   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMIODARONE; AMITRIPTYLINE; ASTEMIZOLE; BROMOCRIPTINE; BUDIPINE; CABERGOLINE; CATECHOL METHYLTRANSFERASE INHIBITOR; CHLORPROMAZINE; DECARBOXYLASE INHIBITOR; DIHYDROERGOCRYPTINE; DISOPYRAMIDE; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; HALOPERIDOL; LEVODOPA; LISURIDE; MEMANTINE; MONOAMINE OXIDASE B INHIBITOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PERGOLIDE; PRAMIPEXOLE; PROCAINAMIDE; QUINIDINE; ROPINIROLE; SELEGILINE; SOTALOL; TERFENADINE; THIORIDAZINE; UNINDEXED DRUG;

ARTICLE; DRUG ABSORPTION; DRUG ELIMINATION; KIDNEY FUNCTION; PARKINSON DISEASE; PHARMACEUTICAL CARE; PLASMA PROTEIN BINDING; TABLET FORMULATION;

EID: 0037179802     PISSN: 00119857     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. H. Przuntek, T. Müller: Nichtmedikamentöse, adjuvante Therapie bei der Behandlung des Morbus Parkinson. 106 S., 24 Abb., 30 Tab. Thieme Verlag 1999. ISBN 3-13-105211-2.
2. R. Thümler: Die Parkinson-Krankheit: Antworten auf die 152 häufigsten Fragen. Trias ärztlicher Rat 2001. ISBN 3-89373-437-6.